Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Tekmira Pharmaceuticals Corp proposes public offering of common stock


Monday, 10 Mar 2014 04:30pm EDT 

Tekmira Pharmaceuticals Corp:Offers to sell shares of common stock in an underwritten public offering to raise about US$60 mln.Expects to grant underwriters a 30-day option to purchase additional shares to cover over-allotments if any.Proceeds to be used to develop and advance product candidates through clinical trials as well as for working capital and general corporate purposes.Leerink Partners LLC acting as sole book-running manager for offering.RBC Capital Markets, LLC is acting as lead manager. 

Company Quote

26.01
3.39 +14.99%
22 Sep 2014